25 XP   0   0   10

Jiangsu Kanion Pharmaceutical Co Ltd
Buy, Hold or Sell?

Let's analyse Kanion together

PenkeI guess you are interested in Jiangsu Kanion Pharmaceutical Co Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Jiangsu Kanion Pharmaceutical Co Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Jiangsu Kanion Pharmaceutical Co Ltd

I send you an email if I find something interesting about Jiangsu Kanion Pharmaceutical Co Ltd.

Quick analysis of Kanion (30 sec.)










What can you expect buying and holding a share of Kanion? (30 sec.)

How much money do you get?

How much money do you get?
¥0.03
When do you have the money?
1 year
How often do you get paid?
92.5%

What is your share worth?

Current worth
¥9.20
Expected worth in 1 year
¥9.97
How sure are you?
90.0%

+ What do you gain per year?

Total Gains per Share
¥0.99
Return On Investment
4.7%

For what price can you sell your share?

Current Price per Share
¥21.12
Expected price per share
¥13.70 - ¥24.75
How sure are you?
50%

1. Valuation of Kanion (5 min.)




Live pricePrice per Share (EOD)

¥21.12

Intrinsic Value Per Share

¥8.72 - ¥24.54

Total Value Per Share

¥17.92 - ¥33.75

2. Growth of Kanion (5 min.)




Is Kanion growing?

Current yearPrevious yearGrowGrow %
How rich?$744.6m$656m$62m8.6%

How much money is Kanion making?

Current yearPrevious yearGrowGrow %
Making money$18.5m$15m$3.5m19.1%
Net Profit Margin10.8%9.9%--

How much money comes from the company's main activities?

3. Financial Health of Kanion (5 min.)




What can you expect buying and holding a share of Kanion? (5 min.)

Welcome investor! Kanion's management wants to use your money to grow the business. In return you get a share of Kanion.

What can you expect buying and holding a share of Kanion?

First you should know what it really means to hold a share of Kanion. And how you can make/lose money.

Speculation

The Price per Share of Kanion is ¥21.12. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Kanion.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Kanion, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥9.20. Based on the TTM, the Book Value Change Per Share is ¥0.19 per quarter. Based on the YOY, the Book Value Change Per Share is ¥0.22 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.06 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Kanion.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps0.040.2%0.030.1%0.030.1%0.020.1%0.020.1%
Usd Book Value Change Per Share0.050.2%0.030.1%0.030.1%0.020.1%0.020.1%
Usd Dividend Per Share0.000.0%0.010.0%0.000.0%0.000.0%0.010.0%
Usd Total Gains Per Share0.050.2%0.030.2%0.030.1%0.020.1%0.030.1%
Usd Price Per Share2.84-3.49-2.11-2.18-2.44-
Price to Earnings Ratio16.02-30.52-21.42-24.14-28.22-
Price-to-Total Gains Ratio61.13-184.18-74.20--335.20--126.31-
Price to Book Ratio2.23-2.85-1.88-2.04-3.09-
Price-to-Total Gains Ratio61.13-184.18-74.20--335.20--126.31-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share2.923008
Number of shares342
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.010.00
Usd Book Value Change Per Share0.030.02
Usd Total Gains Per Share0.030.02
Gains per Quarter (342 shares)11.747.25
Gains per Year (342 shares)46.9529.00
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
111363752419
2227284104848
332108131157277
4431451782096106
55418122525120135
66521727229145164
77625331934169193
88628936639193222
99732541344217251
1010836146049241280

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%40.00.00.0100.0%86.00.00.0100.0%
Book Value Change Per Share4.00.00.0100.0%11.01.00.091.7%17.03.00.085.0%36.04.00.090.0%76.010.00.088.4%
Dividend per Share3.00.01.075.0%9.00.03.075.0%17.00.03.085.0%37.00.03.092.5%80.00.06.093.0%
Total Gains per Share4.00.00.0100.0%11.01.00.091.7%17.03.00.085.0%36.04.00.090.0%81.05.00.094.2%

Fundamentals of Kanion

About Jiangsu Kanion Pharmaceutical Co Ltd

Jiangsu Kanion Pharmaceutical Co.,Ltd. researches and develops, produces, and sells Chinese medicines. The company offers medicines in the fields of anti-infections, orthopedics, gynecology, cardio and cerebrovascular, tonic-class, and others. It also provides herb extracts and formula granules, as well as OEM/ODM services. The company was founded in 1975 and is based in Lianyungang, China.

Fundamental data was last updated by Penke on 2024-03-26 18:26:08.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is overpriced.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Jiangsu Kanion Pharmaceutical Co Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Kanion earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare Kanion to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 13.6% means that ¥0.14 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Jiangsu Kanion Pharmaceutical Co Ltd:

  • The MRQ is 13.6%. The company is making a huge profit. +2
  • The TTM is 10.8%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ13.6%TTM10.8%+2.9%
TTM10.8%YOY9.9%+0.9%
TTM10.8%5Y9.8%+1.0%
5Y9.8%10Y11.0%-1.2%
1.1.2. Return on Assets

Shows how efficient Kanion is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Kanion to the Drug Manufacturers - Specialty & Generic industry mean.
  • 2.6% Return on Assets means that Kanion generated ¥0.03 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Jiangsu Kanion Pharmaceutical Co Ltd:

  • The MRQ is 2.6%. Using its assets, the company is less efficient in making profit.
  • The TTM is 2.0%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ2.6%TTM2.0%+0.7%
TTM2.0%YOY1.7%+0.2%
TTM2.0%5Y1.7%+0.3%
5Y1.7%10Y1.8%-0.2%
1.1.3. Return on Equity

Shows how efficient Kanion is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Kanion to the Drug Manufacturers - Specialty & Generic industry mean.
  • 3.6% Return on Equity means Kanion generated ¥0.04 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Jiangsu Kanion Pharmaceutical Co Ltd:

  • The MRQ is 3.6%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 2.7%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ3.6%TTM2.7%+0.9%
TTM2.7%YOY2.4%+0.3%
TTM2.7%5Y2.4%+0.3%
5Y2.4%10Y2.8%-0.4%

1.2. Operating Efficiency of Jiangsu Kanion Pharmaceutical Co Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Kanion is operating .

  • Measures how much profit Kanion makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Kanion to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 0.0% means the company generated ¥0.00  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Jiangsu Kanion Pharmaceutical Co Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM3.0%-3.0%
TTM3.0%YOY9.2%-6.2%
TTM3.0%5Y8.8%-5.8%
5Y8.8%10Y5.4%+3.4%
1.2.2. Operating Ratio

Measures how efficient Kanion is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.17 means that the operating costs are ¥1.17 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of Jiangsu Kanion Pharmaceutical Co Ltd:

  • The MRQ is 1.168. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.152. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.168TTM1.152+0.017
TTM1.152YOY1.179-0.027
TTM1.1525Y1.150+0.001
5Y1.15010Y0.748+0.402

1.3. Liquidity of Jiangsu Kanion Pharmaceutical Co Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Kanion is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 2.52 means the company has ¥2.52 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of Jiangsu Kanion Pharmaceutical Co Ltd:

  • The MRQ is 2.517. The company is able to pay all its short-term debts. +1
  • The TTM is 2.438. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.517TTM2.438+0.079
TTM2.438YOY2.255+0.183
TTM2.4385Y1.966+0.473
5Y1.96610Y1.120+0.846
1.3.2. Quick Ratio

Measures if Kanion is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Kanion to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.69 means the company can pay off ¥0.69 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Jiangsu Kanion Pharmaceutical Co Ltd:

  • The MRQ is 0.692. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.776. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.692TTM0.776-0.084
TTM0.776YOY1.215-0.439
TTM0.7765Y1.000-0.224
5Y1.00010Y1.140-0.140

1.4. Solvency of Jiangsu Kanion Pharmaceutical Co Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Kanion assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Kanion to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.24 means that Kanion assets are financed with 24.4% credit (debt) and the remaining percentage (100% - 24.4%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Jiangsu Kanion Pharmaceutical Co Ltd:

  • The MRQ is 0.244. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.241. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.244TTM0.241+0.003
TTM0.241YOY0.239+0.002
TTM0.2415Y0.273-0.033
5Y0.27310Y0.308-0.035
1.4.2. Debt to Equity Ratio

Measures if Kanion is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Kanion to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 33.4% means that company has ¥0.33 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Jiangsu Kanion Pharmaceutical Co Ltd:

  • The MRQ is 0.334. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.329. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.334TTM0.329+0.006
TTM0.329YOY0.326+0.003
TTM0.3295Y0.395-0.066
5Y0.39510Y0.469-0.074

2. Market Valuation of Jiangsu Kanion Pharmaceutical Co Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings Kanion generates.

  • Above 15 is considered overpriced but always compare Kanion to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 16.02 means the investor is paying ¥16.02 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Jiangsu Kanion Pharmaceutical Co Ltd:

  • The EOD is 16.492. Based on the earnings, the company is fair priced.
  • The MRQ is 16.024. Based on the earnings, the company is fair priced.
  • The TTM is 30.516. Based on the earnings, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD16.492MRQ16.024+0.469
MRQ16.024TTM30.516-14.493
TTM30.516YOY21.422+9.095
TTM30.5165Y24.136+6.380
5Y24.13610Y28.223-4.087
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Jiangsu Kanion Pharmaceutical Co Ltd:

  • The EOD is 14.732. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 14.314. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is -0.782. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD14.732MRQ14.314+0.419
MRQ14.314TTM-0.782+15.096
TTM-0.782YOY25.248-26.031
TTM-0.7825Y7.995-8.778
5Y7.99510Y3.825+4.170
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Kanion is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Jiangsu Kanion Pharmaceutical Co Ltd:

  • The EOD is 2.295. Based on the equity, the company is underpriced. +1
  • The MRQ is 2.230. Based on the equity, the company is underpriced. +1
  • The TTM is 2.853. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD2.295MRQ2.230+0.065
MRQ2.230TTM2.853-0.623
TTM2.853YOY1.877+0.975
TTM2.8535Y2.036+0.817
5Y2.03610Y3.085-1.049
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Jiangsu Kanion Pharmaceutical Co Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.3310.191+74%0.223+48%0.127+160%0.147+125%
Book Value Per Share--9.2018.873+4%8.107+14%7.643+20%6.416+43%
Current Ratio--2.5172.438+3%2.255+12%1.966+28%1.120+125%
Debt To Asset Ratio--0.2440.241+1%0.239+2%0.273-11%0.308-21%
Debt To Equity Ratio--0.3340.329+2%0.326+3%0.395-15%0.469-29%
Dividend Per Share--0.0040.057-93%0.001+296%0.026-84%0.054-92%
Eps--0.3200.226+41%0.186+72%0.175+83%0.166+92%
Free Cash Flow Per Share--0.3580.318+13%0.336+7%0.273+31%0.162+121%
Free Cash Flow To Equity Per Share--0.3580.318+13%0.264+36%0.160+124%0.127+183%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--24.544--------
Intrinsic Value_10Y_min--8.721--------
Intrinsic Value_1Y_max--1.457--------
Intrinsic Value_1Y_min--0.691--------
Intrinsic Value_3Y_max--5.143--------
Intrinsic Value_3Y_min--2.248--------
Intrinsic Value_5Y_max--9.749--------
Intrinsic Value_5Y_min--3.979--------
Market Cap12349878435.840+3%11999038235.04014742961911.400-19%8917407488.000+35%9255539807.979+30%10342253540.291+16%
Net Profit Margin--0.1360.108+27%0.099+38%0.098+39%0.110+25%
Operating Margin---0.030-100%0.092-100%0.088-100%0.054-100%
Operating Ratio--1.1681.152+1%1.179-1%1.150+2%0.748+56%
Pb Ratio2.295+3%2.2302.853-22%1.877+19%2.036+10%3.085-28%
Pe Ratio16.492+3%16.02430.516-47%21.422-25%24.136-34%28.223-43%
Price Per Share21.120+3%20.52025.213-19%15.250+35%15.753+30%17.614+16%
Price To Free Cash Flow Ratio14.732+3%14.314-0.782+105%25.248-43%7.995+79%3.825+274%
Price To Total Gains Ratio62.915+3%61.128184.180-67%74.202-18%-335.195+648%-126.315+307%
Quick Ratio--0.6920.776-11%1.215-43%1.000-31%1.140-39%
Return On Assets--0.0260.020+35%0.017+52%0.017+59%0.018+43%
Return On Equity--0.0360.027+35%0.024+52%0.024+52%0.028+29%
Total Gains Per Share--0.3360.248+35%0.225+50%0.153+119%0.201+67%
Usd Book Value--744668499.199718089348.292+4%656080700.127+14%622232484.481+20%522533754.975+43%
Usd Book Value Change Per Share--0.0460.026+74%0.031+48%0.018+160%0.020+125%
Usd Book Value Per Share--1.2731.228+4%1.122+14%1.058+20%0.888+43%
Usd Dividend Per Share--0.0010.008-93%0.000+296%0.004-84%0.007-92%
Usd Eps--0.0440.031+41%0.026+72%0.024+83%0.023+92%
Usd Free Cash Flow--29004430.92425725890.666+13%27155886.322+7%22224264.101+31%13203264.440+120%
Usd Free Cash Flow Per Share--0.0500.044+13%0.046+7%0.038+31%0.022+121%
Usd Free Cash Flow To Equity Per Share--0.0500.044+13%0.036+36%0.022+124%0.018+183%
Usd Market Cap1709223175.520+3%1660666891.7302040425928.538-19%1234169196.339+35%1280966709.424+30%1431367889.976+16%
Usd Price Per Share2.923+3%2.8403.489-19%2.111+35%2.180+30%2.438+16%
Usd Profit--25909397.26718570957.592+40%15032573.202+72%14266686.169+82%13571920.027+91%
Usd Revenue--189853754.188168426111.903+13%150540168.512+26%141617613.645+34%124386194.014+53%
Usd Total Gains Per Share--0.0460.034+35%0.031+50%0.021+119%0.028+67%
 EOD+4 -4MRQTTM+23 -12YOY+28 -75Y+27 -810Y+28 -7

3.2. Fundamental Score

Let's check the fundamental score of Jiangsu Kanion Pharmaceutical Co Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1516.492
Price to Book Ratio (EOD)Between0-12.295
Net Profit Margin (MRQ)Greater than00.136
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.692
Current Ratio (MRQ)Greater than12.517
Debt to Asset Ratio (MRQ)Less than10.244
Debt to Equity Ratio (MRQ)Less than10.334
Return on Equity (MRQ)Greater than0.150.036
Return on Assets (MRQ)Greater than0.050.026
Total4/10 (40.0%)

3.3. Technical Score

Let's check the technical score of Jiangsu Kanion Pharmaceutical Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5055.070
Ma 20Greater thanMa 5020.871
Ma 50Greater thanMa 10018.898
Ma 100Greater thanMa 20019.015
OpenGreater thanClose21.320
Total3/5 (60.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in CNY. All numbers in thousands.

Summary
Total Assets7,117,322
Total Liabilities1,736,769
Total Stockholder Equity5,192,797
 As reported
Total Liabilities 1,736,769
Total Stockholder Equity+ 5,192,797
Total Assets = 7,117,322

Assets

Total Assets7,117,322
Total Current Assets4,049,719
Long-term Assets3,067,602
Total Current Assets
Cash And Cash Equivalents 1,969,273
Short-term Investments 460,000
Net Receivables 653,766
Inventory 350,108
Other Current Assets 73,362
Total Current Assets  (as reported)4,049,719
Total Current Assets  (calculated)3,506,509
+/- 543,210
Long-term Assets
Property Plant Equipment 2,507,991
Goodwill 58,989
Intangible Assets 369,082
Long-term Assets Other 55,595
Long-term Assets  (as reported)3,067,602
Long-term Assets  (calculated)2,991,657
+/- 75,945

Liabilities & Shareholders' Equity

Total Current Liabilities1,608,688
Long-term Liabilities128,081
Total Stockholder Equity5,192,797
Total Current Liabilities
Accounts payable 228,419
Other Current Liabilities 3,257
Total Current Liabilities  (as reported)1,608,688
Total Current Liabilities  (calculated)231,676
+/- 1,377,012
Long-term Liabilities
Long-term Liabilities  (as reported)128,081
Long-term Liabilities  (calculated)0
+/- 128,081
Total Stockholder Equity
Retained Earnings 4,251,577
Total Stockholder Equity (as reported)5,192,797
Total Stockholder Equity (calculated)4,251,577
+/- 941,220
Other
Capital Stock584,748
Common Stock Shares Outstanding 584,748
Net Invested Capital 5,192,797
Net Working Capital 2,441,031
Property Plant and Equipment Gross 3,876,867



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-312004-09-302004-06-302004-03-312003-12-312003-09-302003-06-302003-03-312002-12-312002-09-302002-06-302001-12-312000-12-31
> Total Assets 
175,930
177,524
207,607
463,446
426,072
445,144
509,208
640,602
778,434
792,879
811,327
832,103
784,980
864,516
905,120
964,555
990,506
998,479
989,889
966,955
936,106
944,089
949,781
985,936
1,031,759
1,382,867
1,394,535
1,427,199
1,310,570
1,323,015
1,313,655
1,399,514
1,445,408
1,523,332
1,700,329
1,911,627
1,987,481
2,133,034
2,276,505
2,461,546
2,581,407
2,770,967
2,760,266
2,910,344
3,124,858
3,066,788
3,169,650
3,334,823
3,432,194
3,542,219
3,612,736
3,693,110
4,154,972
4,137,738
4,197,561
4,357,563
4,304,503
4,355,958
4,510,492
4,573,204
4,730,105
4,909,003
5,054,957
5,086,190
5,393,710
5,242,282
5,434,099
5,358,705
5,602,950
5,513,315
5,973,332
5,878,870
6,110,822
6,109,839
6,059,165
5,982,358
6,118,508
5,966,485
5,832,096
5,750,412
6,018,019
5,984,973
6,001,672
6,153,703
6,795,804
6,718,199
6,804,353
6,695,868
7,117,322
7,117,3226,695,8686,804,3536,718,1996,795,8046,153,7036,001,6725,984,9736,018,0195,750,4125,832,0965,966,4856,118,5085,982,3586,059,1656,109,8396,110,8225,878,8705,973,3325,513,3155,602,9505,358,7055,434,0995,242,2825,393,7105,086,1905,054,9574,909,0034,730,1054,573,2044,510,4924,355,9584,304,5034,357,5634,197,5614,137,7384,154,9723,693,1103,612,7363,542,2193,432,1943,334,8233,169,6503,066,7883,124,8582,910,3442,760,2662,770,9672,581,4072,461,5462,276,5052,133,0341,987,4811,911,6271,700,3291,523,3321,445,4081,399,5141,313,6551,323,0151,310,5701,427,1991,394,5351,382,8671,031,759985,936949,781944,089936,106966,955989,889998,479990,506964,555905,120864,516784,980832,103811,327792,879778,434640,602509,208445,144426,072463,446207,607177,524175,930
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,804,067
2,670,245
2,834,192
2,729,738
2,929,033
2,764,118
2,905,312
2,886,789
2,842,337
2,855,954
2,885,691
2,759,112
2,654,492
2,607,154
2,874,219
2,859,681
2,913,381
3,090,341
3,729,860
3,687,498
3,771,502
3,631,010
4,049,719
4,049,7193,631,0103,771,5023,687,4983,729,8603,090,3412,913,3812,859,6812,874,2192,607,1542,654,4922,759,1122,885,6912,855,9542,842,3372,886,7892,905,3122,764,1182,929,0332,729,7382,834,1922,670,2452,804,067000000000000000000000000000000000000000000000000000000000000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
257,533
287,360
371,771
267,650
418,585
384,035
408,241
409,299
560,021
617,571
768,812
434,005
666,182
780,075
937,438
721,907
957,365
1,186,529
1,601,300
1,473,330
1,977,320
1,494,166
1,969,273
1,969,2731,494,1661,977,3201,473,3301,601,3001,186,529957,365721,907937,438780,075666,182434,005768,812617,571560,021409,299408,241384,035418,585267,650371,771287,360257,533000000000000000000000000000000000000000000000000000000000000000000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
79,500
0
615
59,500
67,496
85,007
800
48,630
76,330
87,840
4,500
62,000
112,000
146,000
176,000
295,000
225,000
270,000
170,000
202,000
182,000
710,000
460,000
460,000710,000182,000202,000170,000270,000225,000295,000176,000146,000112,00062,0004,50087,84076,33048,63080085,00767,49659,500615079,500000000000000000000000000000000000000000000000000000000000000000000
       Net Receivables 
94,527
85,330
88,169
121,972
110,085
143,036
140,906
194,158
186,087
209,916
213,089
259,574
244,205
281,873
272,804
304,971
285,727
306,486
304,436
323,857
276,527
300,094
275,893
317,853
347,689
391,147
397,618
449,703
381,306
385,012
458,559
527,652
521,839
527,820
646,585
736,315
765,073
812,948
949,695
1,142,069
1,130,013
1,173,995
1,206,313
1,301,129
1,358,504
1,290,856
1,313,866
1,391,146
1,303,966
1,390,508
1,397,364
1,491,564
1,511,101
1,559,721
1,750,048
1,766,774
1,716,471
1,651,121
1,730,806
1,852,070
1,869,542
2,025,507
2,070,319
2,068,923
2,277,423
2,137,288
2,225,993
2,016,830
2,162,749
1,278,041
1,122,175
1,145,654
2,184,085
2,055,175
1,787,850
1,734,066
1,625,553
1,765,804
1,476,387
1,298,372
1,361,791
1,481,070
1,411,870
1,353,458
1,480,416
712,926
1,221,519
660,178
653,766
653,766660,1781,221,519712,9261,480,4161,353,4581,411,8701,481,0701,361,7911,298,3721,476,3871,765,8041,625,5531,734,0661,787,8502,055,1752,184,0851,145,6541,122,1751,278,0412,162,7492,016,8302,225,9932,137,2882,277,4232,068,9232,070,3192,025,5071,869,5421,852,0701,730,8061,651,1211,716,4711,766,7741,750,0481,559,7211,511,1011,491,5641,397,3641,390,5081,303,9661,391,1461,313,8661,290,8561,358,5041,301,1291,206,3131,173,9951,130,0131,142,069949,695812,948765,073736,315646,585527,820521,839527,652458,559385,012381,306449,703397,618391,147347,689317,853275,893300,094276,527323,857304,436306,486285,727304,971272,804281,873244,205259,574213,089209,916186,087194,158140,906143,036110,085121,97288,16985,33094,527
       Other Current Assets 
1,697
9,564
8,720
18,713
4,687
12,816
26,459
48,672
19,502
16,070
20,743
30,363
25,170
25,853
32,111
32,187
2,012
2,187
2,495
1,621
1,629
4,673
4,702
6,283
4,849
8,252
23,745
78,849
52,415
61,644
67,895
92,918
102,463
190,602
147,252
189,763
129,559
146,469
147,313
155,968
197,776
189,381
244,858
223,871
39,742
65,725
66,430
70,637
34,810
42,595
42,120
53,354
45,718
56,571
43,546
54,337
30,229
77,740
42,358
57,190
33,454
30,097
32,012
49,809
18,225
34,860
44,266
159,679
50,176
2,934
3,667
4,013
33,937
41,806
42,639
51,363
110,296
123,343
58,031
47,556
60,912
82,241
40,155
43,531
135,324
50,249
45,906
1,893
73,362
73,3621,89345,90650,249135,32443,53140,15582,24160,91247,55658,031123,343110,29651,36342,63941,80633,9374,0133,6672,93450,176159,67944,26634,86018,22549,80932,01230,09733,45457,19042,35877,74030,22954,33743,54656,57145,71853,35442,12042,59534,81070,63766,43065,72539,742223,871244,858189,381197,776155,968147,313146,469129,559189,763147,252190,602102,46392,91867,89561,64452,41578,84923,7458,2524,8496,2834,7024,6731,6291,6212,4952,1872,01232,18732,11125,85325,17030,36320,74316,07019,50248,67226,45912,8164,68718,7138,7209,5641,697
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,783,577
3,044,300
3,114,752
3,205,510
3,223,050
3,216,828
3,126,403
3,232,818
3,207,373
3,177,604
3,143,258
3,143,800
3,125,292
3,088,291
3,063,363
3,065,945
3,030,702
3,032,852
3,064,858
3,067,602
3,067,6023,064,8583,032,8523,030,7023,065,9453,063,3633,088,2913,125,2923,143,8003,143,2583,177,6043,207,3733,232,8183,126,4033,216,8283,223,0503,205,5103,114,7523,044,3002,783,577000000000000000000000000000000000000000000000000000000000000000000000
       Property Plant Equipment 
33,124
47,350
67,362
132,439
132,836
152,320
174,128
234,533
264,472
303,029
317,201
321,584
336,042
356,235
394,813
353,506
428,347
371,612
419,854
367,930
403,761
371,623
402,885
369,137
435,462
397,448
427,265
389,725
451,965
376,794
456,247
388,439
489,830
445,787
616,258
583,409
771,788
701,505
819,103
745,387
892,625
827,835
886,308
859,137
1,088,617
1,057,246
1,202,061
1,179,164
1,451,865
1,371,891
1,426,977
1,465,210
1,493,379
1,551,036
1,630,025
1,683,644
1,715,117
1,730,239
1,767,872
1,850,910
1,878,212
1,885,262
1,877,281
1,869,721
1,886,959
1,908,184
1,896,408
1,915,976
2,009,272
2,032,372
2,247,506
2,312,625
2,398,683
2,430,242
2,445,873
2,450,610
2,556,893
2,551,010
2,528,925
2,526,637
2,532,816
2,526,753
2,507,142
2,512,962
2,507,812
2,491,368
2,492,595
2,539,627
2,507,991
2,507,9912,539,6272,492,5952,491,3682,507,8122,512,9622,507,1422,526,7532,532,8162,526,6372,528,9252,551,0102,556,8932,450,6102,445,8732,430,2422,398,6832,312,6252,247,5062,032,3722,009,2721,915,9761,896,4081,908,1841,886,9591,869,7211,877,2811,885,2621,878,2121,850,9101,767,8721,730,2391,715,1171,683,6441,630,0251,551,0361,493,3791,465,2101,426,9771,371,8911,451,8651,179,1641,202,0611,057,2461,088,617859,137886,308827,835892,625745,387819,103701,505771,788583,409616,258445,787489,830388,439456,247376,794451,965389,725427,265397,448435,462369,137402,885371,623403,761367,930419,854371,612428,347353,506394,813356,235336,042321,584317,201303,029264,472234,533174,128152,320132,836132,43967,36247,35033,124
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
58,989
58,989
58,989
58,989
58,989
58,989
58,989
58,989
58,989
58,989
58,989
58,989
58,989
64,050
64,050
58,989
58,989
58,989
58,989
58,989
58,989
58,989
58,989
58,989
58,989
58,989
58,989
58,989
58,989
58,989
58,989
58,989
58,989
58,989
58,989
58,989
58,989
58,989
58,989
58,989
58,98958,98958,98958,98958,98958,98958,98958,98958,98958,98958,98958,98958,98958,98958,98958,98958,98958,98958,98958,98958,98958,98958,98958,98958,98964,05064,05058,98958,98958,98958,98958,98958,98958,98958,98958,98958,98958,98958,98958,9890000000000000000000000000000000000000000000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
176,723
176,723
175,723
175,723
176,724
176,724
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000176,724176,724175,723175,723176,723176,723000000000000000000000000000000000000000000000000000000000000000000
       Intangible Assets 
0
0
0
0
0
0
0
42,365
43,248
50,594
48,861
47,652
47,889
46,560
16,569
50,147
42,546
89,717
37,448
71,929
35,294
65,750
29,162
59,252
25,148
54,810
19,173
48,448
11,002
79,750
7,961
75,824
4,909
72,094
2,221
147,595
6,549
173,858
6,627
191,870
6,282
197,841
23,186
213,010
19,413
248,237
17,484
221,007
60,333
239,635
241,810
240,650
273,408
279,387
287,661
295,691
354,919
352,339
346,365
375,520
373,346
366,702
386,562
400,078
392,558
385,813
319,876
314,104
324,082
440,769
252,394
429,349
443,233
458,044
482,315
476,141
481,529
475,370
471,106
438,067
433,848
426,344
423,055
396,924
397,709
390,878
385,023
380,432
369,082
369,082380,432385,023390,878397,709396,924423,055426,344433,848438,067471,106475,370481,529476,141482,315458,044443,233429,349252,394440,769324,082314,104319,876385,813392,558400,078386,562366,702373,346375,520346,365352,339354,919295,691287,661279,387273,408240,650241,810239,63560,333221,00717,484248,23719,413213,01023,186197,8416,282191,8706,627173,8586,549147,5952,22172,0944,90975,8247,96179,75011,00248,44819,17354,81025,14859,25229,16265,75035,29471,92937,44889,71742,54650,14716,56946,56047,88947,65248,86150,59443,24842,3650000000
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
128,829
174,393
119,383
102,598
73,380
24,340
2,489,345
20,142
16,247
15,916
18,420
20,720
17,019
8,195
5,995
21,635
21,974
22,857
20,229
55,595
55,59520,22922,85721,97421,6355,9958,19517,01920,72018,42015,91616,24720,1422,489,34524,34073,380102,598119,383174,393128,829000000000000000000000000000000000000000000000000000000000000000000000
> Total Liabilities 
118,922
103,612
123,455
100,176
92,691
103,549
162,983
276,083
403,556
406,661
421,961
433,715
370,882
435,104
482,875
529,215
532,615
523,888
527,462
490,973
443,193
430,415
453,911
458,793
473,812
513,879
515,963
507,078
355,848
336,863
328,462
363,813
367,227
403,631
573,828
705,406
743,187
844,180
896,652
1,015,969
1,106,579
1,239,527
1,245,195
1,313,430
1,474,232
1,386,899
1,412,705
1,488,192
1,497,649
1,534,869
1,565,728
1,556,229
1,598,725
1,499,585
1,501,039
1,561,791
1,433,756
1,402,290
1,487,823
1,449,369
1,524,287
1,583,283
1,658,901
1,582,522
1,800,207
1,553,692
1,673,432
1,470,479
1,710,721
1,633,814
2,156,014
1,929,578
2,023,392
1,941,075
1,870,364
1,733,005
1,791,780
1,614,265
1,483,406
1,389,138
1,545,299
1,401,874
1,317,588
1,393,009
1,861,812
1,641,295
1,694,501
1,509,151
1,736,769
1,736,7691,509,1511,694,5011,641,2951,861,8121,393,0091,317,5881,401,8741,545,2991,389,1381,483,4061,614,2651,791,7801,733,0051,870,3641,941,0752,023,3921,929,5782,156,0141,633,8141,710,7211,470,4791,673,4321,553,6921,800,2071,582,5221,658,9011,583,2831,524,2871,449,3691,487,8231,402,2901,433,7561,561,7911,501,0391,499,5851,598,7251,556,2291,565,7281,534,8691,497,6491,488,1921,412,7051,386,8991,474,2321,313,4301,245,1951,239,5271,106,5791,015,969896,652844,180743,187705,406573,828403,631367,227363,813328,462336,863355,848507,078515,963513,879473,812458,793453,911430,415443,193490,973527,462523,888532,615529,215482,875435,104370,882433,715421,961406,661403,556276,083162,983103,54992,691100,176123,455103,612118,922
   > Total Current Liabilities 
98,808
68,902
71,760
91,726
82,941
93,400
152,253
255,441
389,677
392,130
407,882
399,615
334,123
398,196
401,107
407,547
464,004
455,128
463,600
429,193
384,933
385,415
408,911
413,793
473,811
513,879
515,963
507,077
351,138
332,152
324,074
359,425
363,450
399,854
520,303
651,881
681,662
762,655
775,127
894,578
955,301
1,016,249
974,868
1,003,104
1,270,996
1,183,908
1,209,729
1,297,616
1,309,893
1,328,461
1,361,553
1,351,429
1,425,078
1,312,123
1,346,652
1,447,262
1,284,817
1,297,733
1,381,393
1,349,283
1,439,419
1,499,385
1,577,697
1,496,022
1,701,507
1,457,790
1,577,965
1,375,056
1,613,276
1,539,349
2,056,032
1,831,010
1,928,373
1,844,329
1,774,049
1,641,658
1,696,042
1,519,253
1,389,637
1,296,304
1,452,856
1,310,316
1,227,998
1,303,532
1,781,106
1,561,334
1,614,610
1,430,606
1,608,688
1,608,6881,430,6061,614,6101,561,3341,781,1061,303,5321,227,9981,310,3161,452,8561,296,3041,389,6371,519,2531,696,0421,641,6581,774,0491,844,3291,928,3731,831,0102,056,0321,539,3491,613,2761,375,0561,577,9651,457,7901,701,5071,496,0221,577,6971,499,3851,439,4191,349,2831,381,3931,297,7331,284,8171,447,2621,346,6521,312,1231,425,0781,351,4291,361,5531,328,4611,309,8931,297,6161,209,7291,183,9081,270,9961,003,104974,8681,016,249955,301894,578775,127762,655681,662651,881520,303399,854363,450359,425324,074332,152351,138507,077515,963513,879473,811413,793408,911385,415384,933429,193463,600455,128464,004407,547401,107398,196334,123399,615407,882392,130389,677255,441152,25393,40082,94191,72671,76068,90298,808
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
675,000
715,000
735,000
685,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000685,000735,000715,000675,000000000000000000000000000000000000000000000000000000000000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
675,000
715,000
735,000
685,000
649,913
582,918
488,000
488,000
342,500
304,500
234,500
234,500
110,000
0
0
0
0
0
0
0
0000000110,000234,500234,500304,500342,500488,000488,000582,918649,913685,000735,000715,000675,000000000000000000000000000000000000000000000000000000000000000000000000
       Accounts payable 
20,539
23,637
20,478
23,081
22,052
25,695
25,347
90,674
92,104
100,784
90,439
95,098
87,139
92,604
118,646
122,150
141,451
142,974
141,247
122,720
131,504
137,302
148,939
125,049
145,416
157,128
180,063
179,478
67,955
74,349
58,194
77,376
84,133
92,091
111,157
137,903
157,277
198,670
183,038
163,101
246,301
242,853
221,012
237,477
232,707
276,458
227,509
284,582
220,551
248,405
272,213
271,021
242,655
345,234
264,052
434,318
340,467
259,007
225,495
229,870
255,858
293,616
300,493
270,568
232,326
262,573
252,202
147,656
210,886
160,537
235,328
197,514
223,274
290,949
289,840
269,454
280,998
357,213
296,117
328,817
359,747
280,696
295,966
316,244
373,364
297,811
230,338
204,236
228,419
228,419204,236230,338297,811373,364316,244295,966280,696359,747328,817296,117357,213280,998269,454289,840290,949223,274197,514235,328160,537210,886147,656252,202262,573232,326270,568300,493293,616255,858229,870225,495259,007340,467434,318264,052345,234242,655271,021272,213248,405220,551284,582227,509276,458232,707237,477221,012242,853246,301163,101183,038198,670157,277137,903111,15792,09184,13377,37658,19474,34967,955179,478180,063157,128145,416125,049148,939137,302131,504122,720141,247142,974141,451122,150118,64692,60487,13995,09890,439100,78492,10490,67425,34725,69522,05223,08120,47823,63720,539
       Other Current Liabilities 
29,177
17,326
21,282
55,645
47,889
54,255
48,366
60,597
59,033
62,806
67,903
74,977
50,884
56,592
54,461
62,397
88,061
84,562
93,361
82,161
81,129
93,263
80,472
104,244
118,895
127,251
126,400
118,099
113,183
92,803
113,880
120,049
116,317
124,763
155,150
213,982
214,295
212,627
235,775
226,477
242,580
264,976
296,856
313,627
326,939
299,680
321,220
377,034
396,342
387,056
435,340
396,409
431,424
418,985
568,732
569,944
521,350
535,726
625,897
934,273
608,681
565,889
677,219
595,455
789,000
710,217
589,639
607,745
693,799
698,991
1,057,766
893,566
269,492
894,513
290,346
862,248
398,576
808,807
344,836
714,328
327,467
907,230
375,439
961,760
593,172
6,093
492,234
1,792
3,257
3,2571,792492,2346,093593,172961,760375,439907,230327,467714,328344,836808,807398,576862,248290,346894,513269,492893,5661,057,766698,991693,799607,745589,639710,217789,000595,455677,219565,889608,681934,273625,897535,726521,350569,944568,732418,985431,424396,409435,340387,056396,342377,034321,220299,680326,939313,627296,856264,976242,580226,477235,775212,627214,295213,982155,150124,763116,317120,049113,88092,803113,183118,099126,400127,251118,895104,24480,47293,26381,12982,16193,36184,56288,06162,39754,46156,59250,88474,97767,90362,80659,03360,59748,36654,25547,88955,64521,28217,32629,177
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
94,465
99,982
98,568
95,019
96,746
96,314
91,347
95,738
95,013
93,768
92,834
92,443
91,559
89,590
89,477
80,706
79,960
79,891
78,544
128,081
128,08178,54479,89179,96080,70689,47789,59091,55992,44392,83493,76895,01395,73891,34796,31496,74695,01998,56899,98294,465000000000000000000000000000000000000000000000000000000000000000000000
       Other Liabilities 
0
6,410
8,410
8,450
9,750
10,149
10,730
20,642
13,879
14,531
14,079
14,100
17,197
17,346
21,206
22,906
9,811
9,960
11,962
13,330
13,260
0
0
0
1
0
0
1
4,710
4,711
4,388
4,388
3,777
3,777
3,525
3,525
3,525
3,525
3,525
3,391
3,278
5,278
7,327
7,326
8,220
7,975
7,976
10,576
20,756
19,408
19,176
19,801
48,647
48,461
54,387
59,529
103,939
104,557
106,390
100,086
84,869
83,897
81,204
86,500
98,700
95,902
95,467
95,423
97,445
94,465
99,982
98,568
95,019
96,746
96,314
91,347
93,812
92,925
91,843
90,909
90,518
89,633
87,664
87,552
78,780
0
77,965
0
0
0077,965078,78087,55287,66489,63390,51890,90991,84392,92593,81291,34796,31496,74695,01998,56899,98294,46597,44595,42395,46795,90298,70086,50081,20483,89784,869100,086106,390104,557103,93959,52954,38748,46148,64719,80119,17619,40820,75610,5767,9767,9758,2207,3267,3275,2783,2783,3913,5253,5253,5253,5253,5253,7773,7774,3884,3884,7114,710100100013,26013,33011,9629,9609,81122,90621,20617,34617,19714,10014,07914,53113,87920,64210,73010,1499,7508,4508,4106,4100
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
99,650
105,086
133,774
134,027
114,527
120,119
134,275
134,865
141,622
143,214
164,695
165,878
168,213
168,940
171,137
170,870
174,286
174,926
184,791
0
184,858
0
0
00184,8580184,791174,926174,286170,870171,137168,940168,213165,878164,695143,214141,622134,865134,275120,119114,527134,027133,774105,08699,650000000000000000000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
55,533
72,301
82,513
361,624
331,715
339,925
344,551
355,867
370,447
381,708
384,744
393,606
409,259
421,677
414,299
427,183
443,639
459,894
447,987
466,066
483,976
504,257
486,136
516,083
546,581
857,267
866,460
907,687
951,463
982,790
981,733
1,032,195
1,071,771
1,112,675
1,119,926
1,171,776
1,209,174
1,252,830
1,344,290
1,408,921
1,435,873
1,484,719
1,474,919
1,555,873
1,611,171
1,640,251
1,716,244
1,805,111
1,878,957
1,951,220
1,989,476
2,079,080
2,499,041
2,580,667
2,637,586
2,736,566
2,810,636
2,893,000
2,960,514
3,062,540
3,143,303
3,230,145
3,297,696
3,407,310
3,485,496
3,580,113
3,650,184
3,766,103
3,768,006
3,744,680
3,680,035
3,811,039
3,936,223
4,016,522
4,033,182
4,094,193
4,166,604
4,190,597
4,186,444
4,193,861
4,304,373
4,414,358
4,515,494
4,585,711
4,754,194
4,895,633
4,925,246
4,999,051
5,192,797
5,192,7974,999,0514,925,2464,895,6334,754,1944,585,7114,515,4944,414,3584,304,3734,193,8614,186,4444,190,5974,166,6044,094,1934,033,1824,016,5223,936,2233,811,0393,680,0353,744,6803,768,0063,766,1033,650,1843,580,1133,485,4963,407,3103,297,6963,230,1453,143,3033,062,5402,960,5142,893,0002,810,6362,736,5662,637,5862,580,6672,499,0412,079,0801,989,4761,951,2201,878,9571,805,1111,716,2441,640,2511,611,1711,555,8731,474,9191,484,7191,435,8731,408,9211,344,2901,252,8301,209,1741,171,7761,119,9261,112,6751,071,7711,032,195981,733982,790951,463907,687866,460857,267546,581516,083486,136504,257483,976466,066447,987459,894443,639427,183414,299421,677409,259393,606384,744381,708370,447355,867344,551339,925331,715361,62482,51372,30155,533
   Common Stock
51,800
51,800
51,800
91,800
91,800
91,800
91,800
91,800
91,800
91,800
156,060
156,060
156,060
156,060
156,060
156,060
156,060
156,060
156,060
156,060
156,060
156,060
156,060
156,060
156,060
166,525
266,440
266,440
266,440
266,440
319,728
319,728
319,728
319,728
319,728
415,647
415,647
415,647
423,247
423,247
423,247
423,247
415,647
415,647
415,647
415,647
415,647
415,647
415,647
415,647
498,776
498,776
513,708
513,708
513,708
513,708
513,708
513,708
616,449
616,449
616,449
616,449
616,449
616,449
616,449
616,449
616,449
616,449
616,449
616,449
592,881
592,881
592,881
592,881
592,881
592,881
592,881
592,881
592,881
592,881
592,881
576,429
576,429
584,598
584,598
0
584,598
0
0
00584,5980584,598584,598576,429576,429592,881592,881592,881592,881592,881592,881592,881592,881592,881592,881592,881616,449616,449616,449616,449616,449616,449616,449616,449616,449616,449616,449616,449513,708513,708513,708513,708513,708513,708498,776498,776415,647415,647415,647415,647415,647415,647415,647415,647423,247423,247423,247423,247415,647415,647415,647319,728319,728319,728319,728319,728266,440266,440266,440266,440166,525156,060156,060156,060156,060156,060156,060156,060156,060156,060156,060156,060156,060156,060156,060156,06091,80091,80091,80091,80091,80091,80091,80051,80051,80051,800
   Retained Earnings 
932
15,587
25,600
35,320
4,746
12,776
17,055
28,359
34,136
45,205
48,288
56,823
62,697
75,114
66,595
79,479
86,166
102,421
89,325
107,223
118,817
138,895
120,818
150,779
171,702
200,022
159,312
200,584
231,783
263,090
262,051
312,498
335,805
376,717
384,003
435,875
455,654
499,327
527,431
592,261
595,365
620,393
673,895
754,847
786,654
815,809
891,825
980,706
1,025,568
1,268,258
1,306,512
1,396,120
1,465,749
1,547,367
1,604,295
1,702,665
1,776,715
1,859,081
1,823,845
1,925,869
2,006,618
2,093,462
2,161,013
2,270,627
2,343,414
2,438,031
2,508,102
2,624,020
2,737,813
2,538,664
2,593,456
2,724,460
3,168,777
3,249,075
3,265,736
3,326,747
3,399,157
3,483,155
3,558,672
3,606,283
3,719,701
3,811,681
3,912,816
3,983,033
4,136,163
3,984,788
4,283,272
4,064,264
4,251,577
4,251,5774,064,2644,283,2723,984,7884,136,1633,983,0333,912,8163,811,6813,719,7013,606,2833,558,6723,483,1553,399,1573,326,7473,265,7363,249,0753,168,7772,724,4602,593,4562,538,6642,737,8132,624,0202,508,1022,438,0312,343,4142,270,6272,161,0132,093,4622,006,6181,925,8691,823,8451,859,0811,776,7151,702,6651,604,2951,547,3671,465,7491,396,1201,306,5121,268,2581,025,568980,706891,825815,809786,654754,847673,895620,393595,365592,261527,431499,327455,654435,875384,003376,717335,805312,498262,051263,090231,783200,584159,312200,022171,702150,779120,818138,895118,817107,22389,325102,42186,16679,47966,59575,11462,69756,82348,28845,20534,13628,35917,05512,7764,74635,32025,60015,587932
   Capital Surplus 00000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Treasury Stock00000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
335
130
0
0
0
0
0
0
0
0
0
000000000130335000000000000000000000000000000000000000000000000000000000000000000000000000000



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in CNY. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue4,867,807
Cost of Revenue-1,252,521
Gross Profit3,615,2863,615,286
 
Operating Income (+$)
Gross Profit3,615,286
Operating Expense-4,339,734
Operating Income528,072-724,449
 
Operating Expense (+$)
Research Development771,690
Selling General Administrative2,114,287
Selling And Marketing Expenses0
Operating Expense4,339,7342,885,978
 
Net Interest Income (+$)
Interest Income24,455
Interest Expense-0
Other Finance Cost-1,457
Net Interest Income22,998
 
Pretax Income (+$)
Operating Income528,072
Net Interest Income22,998
Other Non-Operating Income Expenses0
Income Before Tax (EBT)550,983528,072
EBIT - interestExpense = 0
536,733
536,733
Interest Expense0
Earnings Before Interest and Taxes (EBIT)0550,983
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax550,983
Tax Provision-3,932
Net Income From Continuing Ops547,050547,050
Net Income536,733
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net0-22,998
 

Technical Analysis of Kanion
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Kanion. The general trend of Kanion is BULLISH with 42.9% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Kanion's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (42.9%) Bearish trend (-42.9%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Jiangsu Kanion Pharmaceutical Co Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 24.09 < 24.44 < 24.75.

The bearish price targets are: 18.08 > 17.34 > 13.70.

Tweet this
Jiangsu Kanion Pharmaceutical Co Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Jiangsu Kanion Pharmaceutical Co Ltd. The current mas is .

The long score for the Moving Averages is 10/14.
The longshort score for the Moving Averages is 6/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Jiangsu Kanion Pharmaceutical Co Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Jiangsu Kanion Pharmaceutical Co Ltd. The current macd is 0.85903545.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Kanion price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Kanion. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Kanion price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Jiangsu Kanion Pharmaceutical Co Ltd Daily Moving Average Convergence/Divergence (MACD) ChartJiangsu Kanion Pharmaceutical Co Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Jiangsu Kanion Pharmaceutical Co Ltd. The current adx is 40.88.

The long score for the Directional Movement Index (DMI) is 3/7.
The longshort score for the Directional Movement Index (DMI) is 3/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Kanion shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bullish trend. The ADX is declining, the bullish trend is weakening. Could be a potential reversal to the downside. +2
Jiangsu Kanion Pharmaceutical Co Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Jiangsu Kanion Pharmaceutical Co Ltd. The current sar is 23.58.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Jiangsu Kanion Pharmaceutical Co Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Jiangsu Kanion Pharmaceutical Co Ltd. The current rsi is 55.07. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 3/13.
The longshort score for the Relative Strength Index (RSI) is 2/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending down: The RSI is trending down. -1
Jiangsu Kanion Pharmaceutical Co Ltd Daily Relative Strength Index (RSI) ChartJiangsu Kanion Pharmaceutical Co Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Jiangsu Kanion Pharmaceutical Co Ltd. The current phase is Correction in bull market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -4/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Kanion price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Jiangsu Kanion Pharmaceutical Co Ltd Daily Stochastic Oscillator ChartJiangsu Kanion Pharmaceutical Co Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Jiangsu Kanion Pharmaceutical Co Ltd. The current cci is 19.66.

Jiangsu Kanion Pharmaceutical Co Ltd Daily Commodity Channel Index (CCI) ChartJiangsu Kanion Pharmaceutical Co Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Jiangsu Kanion Pharmaceutical Co Ltd. The current cmo is 2.11448659.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Jiangsu Kanion Pharmaceutical Co Ltd Daily Chande Momentum Oscillator (CMO) ChartJiangsu Kanion Pharmaceutical Co Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Jiangsu Kanion Pharmaceutical Co Ltd. The current willr is -64.56521739.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Kanion is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Jiangsu Kanion Pharmaceutical Co Ltd Daily Williams %R ChartJiangsu Kanion Pharmaceutical Co Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Jiangsu Kanion Pharmaceutical Co Ltd.

Jiangsu Kanion Pharmaceutical Co Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Jiangsu Kanion Pharmaceutical Co Ltd. The current atr is 0.88960906.

Jiangsu Kanion Pharmaceutical Co Ltd Daily Average True Range (ATR) ChartJiangsu Kanion Pharmaceutical Co Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Jiangsu Kanion Pharmaceutical Co Ltd. The current obv is 305,053,507.

Jiangsu Kanion Pharmaceutical Co Ltd Daily On-Balance Volume (OBV) ChartJiangsu Kanion Pharmaceutical Co Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Jiangsu Kanion Pharmaceutical Co Ltd. The current mfi is 55.25.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Jiangsu Kanion Pharmaceutical Co Ltd Daily Money Flow Index (MFI) ChartJiangsu Kanion Pharmaceutical Co Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Jiangsu Kanion Pharmaceutical Co Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-03STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-06MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-07DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-11-08CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-11-09STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-13STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-14WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-11-15STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-17STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-11-20CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-11-21STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-23STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-11-24BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-11-27STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-28MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-11-30SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-12-01STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-04SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-05STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-07SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-11MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-12WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-13RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-18STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-12-20WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-12-22RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-25SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-12-26MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-27CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-28STOCH SHORT EXITThe %K line crosses above the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-29STOCH LONG EXITThe %K line crosses below the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-03MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-10SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-11CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-12DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-17DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-01-18DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-01-19STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-22BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-30STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-31BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-06RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-07SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-08CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-19MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-20WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-21DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-29WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-04CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-11CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-18ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-19RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-22SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-26MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-03-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-28STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

Jiangsu Kanion Pharmaceutical Co Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Jiangsu Kanion Pharmaceutical Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5055.070
Ma 20Greater thanMa 5020.871
Ma 50Greater thanMa 10018.898
Ma 100Greater thanMa 20019.015
OpenGreater thanClose21.320
Total3/5 (60.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Kanion with someone you think should read this too:
  • Are you bullish or bearish on Kanion? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Kanion? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Jiangsu Kanion Pharmaceutical Co Ltd

I send you an email if I find something interesting about Jiangsu Kanion Pharmaceutical Co Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Jiangsu Kanion Pharmaceutical Co Ltd.

Receive notifications about Jiangsu Kanion Pharmaceutical Co Ltd in your mailbox!